Published in EMBO J on July 01, 1987
Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol (1989) 6.55
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol (1994) 6.00
Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49
Role of transforming growth factor-beta in the development of the mouse embryo. J Cell Biol (1987) 3.48
The immune system and cardiac repair. Pharmacol Res (2008) 3.42
Macrophages in rheumatoid arthritis. Arthritis Res (2000) 3.40
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol (1990) 3.04
Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med (1989) 2.99
Cytokines in context. J Cell Biol (1991) 2.65
Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol (1990) 2.65
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax (1999) 2.63
Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest (1990) 2.61
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol (1989) 2.54
Organising pneumonia. Thorax (2000) 2.51
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol (1994) 2.27
Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J (1990) 2.21
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med (1990) 2.19
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A (1999) 2.17
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol (1993) 2.16
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol (1994) 2.15
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol (1989) 2.05
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J (1992) 1.91
Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol (2002) 1.78
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol (1992) 1.72
Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol (1993) 1.71
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol (1989) 1.70
Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol (1991) 1.69
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67
Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut (1999) 1.66
Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol (1994) 1.64
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest (1992) 1.62
Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol (1995) 1.58
Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest (1993) 1.56
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol (1991) 1.55
Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci U S A (1993) 1.52
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest (1994) 1.52
Transforming growth factor-beta: possible roles in carcinogenesis. Br J Cancer (1988) 1.51
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
Regulation of cell surface beta 1 integrin levels during keratinocyte terminal differentiation. J Cell Biol (1995) 1.48
Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am J Pathol (1998) 1.48
Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity. Arthritis Res Ther (2005) 1.47
Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut (2001) 1.47
Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest (1992) 1.45
Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res (2008) 1.42
Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225). EMBO J (1992) 1.38
Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest (1996) 1.38
Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant (2009) 1.35
Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med (1996) 1.34
Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol (2004) 1.33
Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J (1997) 1.26
cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci U S A (1990) 1.26
Transforming growth factor beta 1 gene expression in human airways. Thorax (1994) 1.24
Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol (2010) 1.23
Transforming growth factor beta 1 regulates production of acute-phase proteins. Proc Natl Acad Sci U S A (1990) 1.23
Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev (2004) 1.22
Current concepts in metastasis. Gut (1994) 1.21
Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol (1991) 1.21
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest (1995) 1.21
Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest (1992) 1.21
Elevated cysteine-rich 61 mediates aberrant collagen homeostasis in chronologically aged and photoaged human skin. Am J Pathol (2006) 1.20
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest (1995) 1.18
Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul (1990) 1.16
Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Invest Ophthalmol Vis Sci (2010) 1.16
Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer (1992) 1.15
Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J (2004) 1.15
Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol (1999) 1.14
How does TGF-β mediate tubulointerstitial fibrosis? Semin Nephrol (2012) 1.14
Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis (1997) 1.14
TGFbeta1 regulates gene expression of its own converting enzyme furin. J Clin Invest (1997) 1.13
Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res (1992) 1.11
Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol (1994) 1.11
Gene expression changes during the development of acute lung injury: role of transforming growth factor beta. Am J Respir Crit Care Med (2005) 1.10
Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell (1999) 1.07
Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction. Clin Exp Immunol (1991) 1.07
Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis (1993) 1.06
Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer (1994) 1.05
Modulation of NCAM expression by transforming growth factor-beta, serum, and autocrine factors. J Cell Biol (1990) 1.05
HCG variants, the growth factors which drive human malignancies. Am J Cancer Res (2011) 1.05
Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res (1995) 1.04
Longitudinal mechanical tension induces growth in the small bowel of juvenile rats. Gut (2005) 1.04
Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) (2009) 1.03
hCG, the wonder of today's science. Reprod Biol Endocrinol (2012) 1.03
Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A (1994) 1.03
Monocytic cell type-specific transcriptional induction of collagenase. J Clin Invest (1996) 1.02
Complements and the wound healing cascade: an updated review. Plast Surg Int (2013) 1.01
A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res (2005) 1.00
Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol (2007) 1.00
Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J (1995) 1.00
Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer (1999) 0.98
Protein kinase C activation potently down-regulates the expression of its major substrate, 80K, in Swiss 3T3 cells. EMBO J (1991) 0.98
Cytokine profiles in localized scleroderma and relationship to clinical features. Cytokine (2011) 0.98
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
Maternal obesity induces fibrosis in fetal myocardium of sheep. Am J Physiol Endocrinol Metab (2010) 0.96
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell (1985) 10.00
Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol (1981) 9.97
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell (1986) 9.10
Autocrine growth factors and cancer. Nature (1985) 5.97
Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (1980) 5.84
Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08
A cyclic AMP- and phorbol ester-inducible DNA element. Nature (1986) 4.60
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J (1985) 3.60
Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 3.52
Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49
Growth factors and cancer. Cancer Res (1986) 3.48
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest (1986) 3.43
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature (1987) 3.31
A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17
Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol (1986) 2.74
Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem (1986) 2.61
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol (1986) 2.44
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17
Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12
The release of collagenase as an inactive proenzyme by bone explants in culture. Biochem J (1972) 1.99
Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86
Transcriptional regulation of two serum-induced RNAs in mouse fibroblasts: equivalence of one species to B2 repetitive elements. Mol Cell Biol (1985) 1.73
Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65
The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J Biol Chem (1986) 1.65
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62
An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J (1981) 1.52
Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Relat Res (1986) 1.50
Regulation of the mammalian collagenases. Coll Relat Res (1984) 1.49
Transformation-dependent secretion of a low molecular weight protein by murine fibroblasts. Proc Natl Acad Sci U S A (1978) 1.44
Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. J Biol Chem (1985) 1.42
Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. J Biol Chem (1983) 1.42
A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res (1986) 1.25
Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate. J Cell Biol (1986) 1.23
Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoic acid or dexamethasone. Biochemistry (1986) 1.21
Structure and properties of the cellular receptor for transforming growth factor type beta. Biochemistry (1986) 1.19
Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. EMBO J (1986) 1.19
Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis. J Oral Pathol (1986) 1.03
Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins. Cancer Res (1986) 1.01
The effects of platelet-derived transforming growth factor beta on normal human diploid gingival fibroblasts. Eur J Biochem (1986) 0.99
Proactivator-dependent activation of procollagenase induced by treatment with EGTA. Biochem J (1986) 0.84
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature (1988) 7.61
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell (1991) 6.89
floricaula: a homeotic gene required for flower development in antirrhinum majus. Cell (1990) 6.52
DNA binding of the glucocorticoid receptor is not essential for survival. Cell (1998) 6.40
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J Cell Biol (2001) 5.05
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region. Mol Cell Biol (1987) 4.86
FCA, a gene controlling flowering time in Arabidopsis, encodes a protein containing RNA-binding domains. Cell (1997) 4.79
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Multiple independent defective suppressor-mutator transposon insertions in Arabidopsis: a tool for functional genomics. Plant Cell (1999) 4.57
Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature (1989) 4.42
ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J (1995) 4.28
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell (1989) 4.17
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell (1996) 3.60
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem (1985) 3.51
Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature (1987) 3.31
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J (1993) 3.28
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A (1998) 3.27
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett (1998) 3.04
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett (1992) 2.88
Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J (1993) 2.83
Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol (1990) 2.73
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
Posttranscriptional regulation of c-fos mRNA expression. Nucleic Acids Res (1987) 2.66
Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene (1995) 2.64
Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol (1986) 2.63
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Conservation of microstructure between a sequenced region of the genome of rice and multiple segments of the genome of Arabidopsis thaliana. Genome Res (2001) 2.56
Molecular characterization and regulation of the rhizosphere-expressed genes rhiABCR that can influence nodulation by Rhizobium leguminosarum biovar viciae. J Bacteriol (1992) 2.55
Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J (1987) 2.54
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53
Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc Natl Acad Sci U S A (1988) 2.51
Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J (1984) 2.47
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Airborne spread of measles in a suburban elementary school. Am J Epidemiol (1978) 2.37
Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol (1988) 2.37
Stimulation by endocytosis of the secretion of collagenase and neutral proteinase from rabbit synovial fibroblasts. J Exp Med (1974) 2.36
c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell (2000) 2.35
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J (2001) 2.34
Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol (2000) 2.33
Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
Different requirements for formation of Jun: Jun and Jun: Fos complexes. Genes Dev (1989) 2.22
The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol (1992) 2.19
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen (2000) 2.15
A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol (1997) 2.13
Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem (2000) 2.12
Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12
Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron (1998) 2.11
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell (1990) 2.10
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res (1996) 2.09
Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A (1980) 2.08
Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development (1997) 2.07
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
Most highly repeated dispersed DNA families in the mouse genome. Mol Cell Biol (1984) 2.04
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett (2000) 2.03
Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell (1995) 2.01
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development (1999) 1.98
Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett (1996) 1.97
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science (1997) 1.93
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis (1997) 1.92
Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology (1996) 1.91
ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun (2000) 1.90
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89
Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86
UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J (1993) 1.86
The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem (1992) 1.85
The role of the C-terminal domain in collagenase and stromelysin specificity. J Biol Chem (1992) 1.85
Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet (1998) 1.83
The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol (1996) 1.82
Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development (2000) 1.82